1173 related articles for article (PubMed ID: 1676038)
21. Relative contribution of CD2 and LFA-1 to murine T and natural killer cell functions.
Nakamura T; Takahashi K; Fukazawa T; Koyanagi M; Yokoyama A; Kato H; Yagita H; Okumura K
J Immunol; 1990 Dec; 145(11):3628-34. PubMed ID: 1700989
[TBL] [Abstract][Full Text] [Related]
22. Contributions of the CD2 and CD28 T lymphocyte activation pathways to the regulation of the expression of the colony-stimulating factor (CSF-1) gene.
Cerdan C; Razanajaona D; Martin Y; Courcoul M; Pavon C; Mawas C; Olive D; Birg F
J Immunol; 1992 Jul; 149(2):373-9. PubMed ID: 1352526
[TBL] [Abstract][Full Text] [Related]
23. Differential expression of the interleukin 2 receptor beta (p75) chain on human peripheral blood natural killer subsets.
Nishikawa K; Saito S; Morii T; Kato Y; Narita N; Ichijo M; Ohashi Y; Takeshita T; Sugamura K
Int Immunol; 1990; 2(6):481-6. PubMed ID: 1707657
[TBL] [Abstract][Full Text] [Related]
24. Characterization of functional surface structures on human natural killer cells.
Ritz J; Schmidt RE; Michon J; Hercend T; Schlossman SF
Adv Immunol; 1988; 42():181-211. PubMed ID: 3284289
[TBL] [Abstract][Full Text] [Related]
25. Granulocyte-macrophage colony-stimulating factor expression is regulated at transcriptional and posttranscriptional levels in a murine bone marrow stromal cell line.
Derigs HG; Reifel-Miller A; Kaushansky K; Hromas RA; Boswell HS
Exp Hematol; 1994 Aug; 22(9):924-32. PubMed ID: 8062890
[TBL] [Abstract][Full Text] [Related]
26. Natural killer cells activated by interleukin 2 treatment in vivo respond to interleukin 2 primarily through the p75 receptor and maintain the p55 (TAC) negative phenotype.
Weil-Hillman G; Voss SD; Fisch P; Schell K; Hank JA; Sosman JA; Sugamura K; Sondel PM
Cancer Res; 1990 May; 50(9):2683-91. PubMed ID: 1691679
[TBL] [Abstract][Full Text] [Related]
27. Differential effects of interleukin-3, interleukin-7, interleukin 15, and granulocyte-macrophage colony-stimulating factor in the generation of natural killer and B cells from primitive human fetal liver progenitors.
Muench MO; Humeau L; Paek B; Ohkubo T; Lanier LL; Albanese CT; Bárcena A
Exp Hematol; 2000 Aug; 28(8):961-73. PubMed ID: 10989197
[TBL] [Abstract][Full Text] [Related]
28. Coinduction of granulocyte-macrophage colony-stimulating factor release and lymphokine-activated killer cell susceptibility in monocytes by interleukin-2 via interleukin-2 receptor beta.
Epling-Burnette PK; Wei S; Blanchard DK; Spranzi E; Djeu JY
Blood; 1993 Jun; 81(11):3130-7. PubMed ID: 8499646
[TBL] [Abstract][Full Text] [Related]
29. Comitogenic effect of solid-phase immobilized anti-1F7 on human CD4 T cell activation via CD3 and CD2 pathways.
Dang NH; Torimoto Y; Deusch K; Schlossman SF; Morimoto C
J Immunol; 1990 Jun; 144(11):4092-100. PubMed ID: 1971293
[TBL] [Abstract][Full Text] [Related]
30. Recombinant granulocyte-macrophage colony-stimulating factor down-regulates expression of IL-2 receptor on human mononuclear phagocytes by induction of prostaglandin E.
Hancock WW; Pleau ME; Kobzik L
J Immunol; 1988 May; 140(9):3021-5. PubMed ID: 3129507
[TBL] [Abstract][Full Text] [Related]
31. Role of CD2 cross-linking in cytoplasmic calcium responses and T cell activation.
Ledbetter JA; Rabinovitch PS; Hellström I; Hellström KE; Grosmaire LS; June CH
Eur J Immunol; 1988 Oct; 18(10):1601-8. PubMed ID: 2461308
[TBL] [Abstract][Full Text] [Related]
32. Human natural killer cell adhesion molecules. Differential expression after activation and participation in cytolysis.
Robertson MJ; Caligiuri MA; Manley TJ; Levine H; Ritz J
J Immunol; 1990 Nov; 145(10):3194-201. PubMed ID: 1700001
[TBL] [Abstract][Full Text] [Related]
33. Rapid Il-2-induced adherence of human natural killer cells. Expression of mRNA for cytokines and IL-2 receptors in adherent NK cells.
Vitolo D; Vujanovic NL; Rabinowich H; Schlesinger M; Herberman RB; Whiteside TL
J Immunol; 1993 Aug; 151(4):1926-37. PubMed ID: 8345189
[TBL] [Abstract][Full Text] [Related]
34. Modulation of lymphokine release and cytolytic activities by activating peripheral blood lymphocytes via CD2.
Valentin H; Groux H; Gelin C; Chretien I; Bernard A
J Immunol; 1990 Feb; 144(3):875-82. PubMed ID: 1967277
[TBL] [Abstract][Full Text] [Related]
35. A novel functional cell surface dimer (Kp43) expressed by natural killer cells and gamma/delta TCR+ T lymphocytes. II. Modulation of natural killer cytotoxicity by anti-Kp43 monoclonal antibody.
Aramburu J; Balboa MA; Izquierdo M; López-Botet M
J Immunol; 1991 Jul; 147(2):714-21. PubMed ID: 1830071
[TBL] [Abstract][Full Text] [Related]
36. Human resting B lymphocytes can serve as accessory cells for anti-CD2-induced T cell activation.
Hirokawa M; Gray JD; Takahashi T; Horwitz DA
J Immunol; 1992 Sep; 149(6):1859-66. PubMed ID: 1355500
[TBL] [Abstract][Full Text] [Related]
37. Interaction of CD2 with its ligand lymphocyte function-associated antigen-3 induces adenosine 3',5'-cyclic monophosphate production in T lymphocytes.
Hahn WC; Rosenstein Y; Burakoff SJ; Bierer BE
J Immunol; 1991 Jul; 147(1):14-21. PubMed ID: 1711070
[TBL] [Abstract][Full Text] [Related]
38. Interleukin-5 is the predominant eosinophilopoietin produced by cloned T lymphocytes in hypereosinophilic syndrome.
Schrezenmeier H; Thomé SD; Tewald F; Fleischer B; Raghavachar A
Exp Hematol; 1993 Feb; 21(2):358-65. PubMed ID: 8425573
[TBL] [Abstract][Full Text] [Related]
39. Production of granulocyte-macrophage colony-stimulating factor by human trophoblast cells and by decidual large granular lymphocytes.
Jokhi PP; King A; Loke YW
Hum Reprod; 1994 Sep; 9(9):1660-9. PubMed ID: 7530725
[TBL] [Abstract][Full Text] [Related]
40. Production of granulocyte-macrophage colony-stimulating factor but not IL-3 by normal and neoplastic human B lymphocytes.
Zupo S; Perussia B; Baldi L; Corcione A; Dono M; Ferrarini M; Pistoia V
J Immunol; 1992 Mar; 148(5):1423-30. PubMed ID: 1538127
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
